Advertisement
Screener

ROCKWELL MEDICAL, INC. (RMTI) Number of Reportable Segments

2.8 / 5 stars · 68/120 Roast Me

ROCKWELL MEDICAL, INC. Number of Reportable Segments

ROCKWELL MEDICAL, INC. (RMTI) reported Number of Reportable Segments of 1 segment for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.

Financial Statements › Notes › Segment Reporting

us-gaap:NumberOfReportableSegments · last filed 2026-08-13

  • ROCKWELL MEDICAL, INC. number of reportable segments for the quarter ending 2026-03-31 was 1.00 segment.
  • ROCKWELL MEDICAL, INC. number of reportable segments for the quarter ending 2018-03-31 was 2.00 segment.
  • ROCKWELL MEDICAL, INC. number of reportable segments for fiscal 2025 was 1.00 segment, a 0.00% change from fiscal 2024.
  • ROCKWELL MEDICAL, INC. number of reportable segments for fiscal 2024 was 1.00 segment, a 0.00% change from fiscal 2023.
  • ROCKWELL MEDICAL, INC. number of reportable segments for fiscal 2023 was 1.00 segment.

segment

Period endNumber of Reportable Segments 3 monthNumber of Reportable Segments 6 monthNumber of Reportable Segments 9 monthNumber of Reportable Segments 12 month
2026-06-301.00 segment
10-Q · filed 2026-08-13
2026-03-311.00 segment
10-Q · filed 2026-05-07
2025-12-311.00 segment
10-K · filed 2026-03-26
2025-09-301.00 segment
10-Q · filed 2025-11-12
2025-06-301.00 segment
10-Q · filed 2025-08-14
2024-12-311.00 segment
10-K · filed 2025-03-20
2023-12-311.00 segment
10-K · filed 2025-03-20
2018-03-312.00 segment
10-Q/A · filed 2018-08-14

tradingDay

Period endNumber of Reportable Segments 3 monthNumber of Reportable Segments 6 monthNumber of Reportable Segments 9 month
2026-06-301.00 tradingDay
10-Q · filed 2026-08-13
2026-03-311.00 tradingDay
10-Q · filed 2026-05-07
2025-09-301.00 tradingDay
10-Q · filed 2025-11-12
2025-06-301.00 tradingDay
10-Q · filed 2026-08-13
2025-03-311.00 tradingDay
10-Q · filed 2026-05-07
2024-09-301.00 tradingDay
10-Q · filed 2025-11-12
2024-06-301.00 tradingDay
10-Q · filed 2025-08-14

Similar stocks

Stock NameCountryMarket CapPE Ratio
Context Therapeutics Inc. (CNTX)United States$0.034B-1.10
MIRA PHARMACEUTICALS, INC. (MIRA)United States$0.036B-4.30
Seres Therapeutics, Inc. (MCRB)United States$0.036B-3.45
Propanc Biopharma, Inc. (PPCB)$0.032B-0.13
BriaCell Therapeutics Corp. (BCTX)$0.037B
CHINA PHARMA HOLDINGS, INC. (CPHI)$0.032B
PMGC Holdings Inc. (ELAB)United States$0.037B
FILANA THERAPEUTICS, INC. (FLNA)United States$0.038B-1.05
Actinium Pharmaceuticals, Inc. (ATNM)United States$0.038B2.73
NANOVIRICIDES, INC. (NNVC)United States$0.031B